1-13 of 13
Ping Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Free
Anand Shah, Erik Bloomquist, Shenghui Tang, Wentao Fu, Youwei Bi, Qi Liu, Jingyu Yu, Ping Zhao, Todd R. Palmby, Kirsten B. Goldberg, C.J. George Chang, Paresma Patel, Elleni Alebachew, Amy Tilley, William F. Pierce, Amna Ibrahim, Gideon M. Blumenthal, Rajeshwari Sridhara, Julia A. Beaver, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (13): 2999–3004.
https://doi.org/10.1158/1078-0432.CCR-17-2369
Published: 01 July 2018
View articletitled, FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Open the PDF for FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer in another window
Journal Articles

FDA Approval: Blinatumomab

Free
Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, Carolyn L. Yancey, Reyes Candau-Chacon, Haw-Jyh Chiu, Brenda J. Gehrke, Candace Gomez-Broughton, Robert C. Kane, Susan Kirshner, Nitin Mehrotra, Tiffany K. Ricks, Deborah Schmiel, Pengfei Song, Ping Zhao, Qing Zhou, Ann T. Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4035–4039.
https://doi.org/10.1158/1078-0432.CCR-15-0612
Published: 14 September 2015
View articletitled, FDA Approval: Blinatumomab
Open the PDF for FDA Approval: Blinatumomab in another window
Includes: Supplementary data
Journal Articles

FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

Free
Sean Khozin, Gideon M. Blumenthal, Lijun Zhang, Shenghui Tang, Margaret Brower, Emily Fox, Whitney Helms, Ruby Leong, Pengfei Song, Yuzhuo Pan, Qi Liu, Ping Zhao, Hong Zhao, Donghao Lu, Zhe Tang, Ali Al Hakim, Karen Boyd, Patricia Keegan, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2436–2439.
https://doi.org/10.1158/1078-0432.CCR-14-3157
Published: 31 May 2015
View articletitled, FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer
Open the PDF for FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer in another window
Journal Articles

A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells

Free
Matthew R. Hight, Yiu-Yin Cheung, Michael L. Nickels, Eric S. Dawson, Ping Zhao, Samir Saleh, Jason R. Buck, Dewei Tang, M. Kay Washington, Robert J. Coffey, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (8): 2126–2135.
https://doi.org/10.1158/1078-0432.CCR-13-2444
Published: 15 April 2014
View articletitled, A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells
Open the PDF for A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells in another window
Includes: Supplementary data
Journal Articles

18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer

Free
Eliot T. McKinley, Joseph E. Bugaj, Ping Zhao, Saffet Guleryuz, Christine Mantis, Prafulla C. Gokhale, Robert Wild, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3332–3340.
https://doi.org/10.1158/1078-0432.CCR-10-2274
Published: 15 May 2011
View articletitled, 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer
Open the PDF for 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Can a Metastatic Gene Expression Profile Outperform Tumor Size as a Predictor of Occult Lymph Node Metastasis in Oral Cancer Patients?

Free
Eduardo Méndez, Pawadee Lohavanichbutr, Wenhong Fan, John R. Houck, Tessa C. Rue, David R. Doody, Neal D. Futran, Melissa P. Upton, Bevan Yueh, Lue Ping Zhao, Stephen M. Schwartz, Chu Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2466–2473.
https://doi.org/10.1158/1078-0432.CCR-10-0175
Published: 14 April 2011
View articletitled, Can a Metastatic Gene Expression Profile Outperform Tumor Size as a Predictor of Occult Lymph Node Metastasis in Oral Cancer Patients?
Open the PDF for Can a Metastatic Gene Expression Profile Outperform Tumor Size as a Predictor of Occult Lymph Node Metastasis in Oral Cancer Patients? in another window
Includes: Supplementary data
Journal Articles

Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis

Free
Hai Hu, Lichao Sun, Chunguang Guo, Qian Liu, Zhuan Zhou, Liang Peng, Jian Pan, Long Yu, Jinning Lou, Zhihua Yang, Ping Zhao, Yuliang Ran
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (17): 5485–5493.
https://doi.org/10.1158/1078-0432.CCR-08-2491
Published: 31 August 2009
View articletitled, Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis
Open the PDF for Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis in another window
Includes: Supplementary data
Journal Articles

Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer

Free
Chirayu Shah, Todd W. Miller, Shelby K. Wyatt, Eliot T. McKinley, Maria Graciela Olivares, Violeta Sanchez, Donald D. Nolting, Jason R. Buck, Ping Zhao, M. Sib Ansari, Ronald M. Baldwin, John C. Gore, Rachel Schiff, Carlos L. Arteaga, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (14): 4712–4721.
https://doi.org/10.1158/1078-0432.CCR-08-2635
Published: 15 July 2009
View articletitled, Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
Open the PDF for Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer in another window
Includes: Supplementary data
Journal Articles

A Genetic Expression Profile Associated with Oral Cancer Identifies a Group of Patients at High Risk of Poor Survival

Free
Eduardo Méndez, John R. Houck, David R. Doody, Wenhong Fan, Pawadee Lohavanichbutr, Tessa C. Rue, Bevan Yueh, Neal D. Futran, Melissa P. Upton, D. Gregory Farwell, Patrick J. Heagerty, Lue Ping Zhao, Stephen M. Schwartz, Chu Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1353–1361.
https://doi.org/10.1158/1078-0432.CCR-08-1816
Published: 19 February 2009
View articletitled, A Genetic Expression Profile Associated with Oral Cancer Identifies a Group of Patients at High Risk of Poor Survival
Open the PDF for A Genetic Expression Profile Associated with Oral Cancer Identifies a Group of Patients at High Risk of Poor Survival in another window
Includes: Supplementary data
Journal Articles

Identification of a Met-Binding Peptide from a Phage Display Library

Free
Ping Zhao, Tessa Grabinski, Chongfeng Gao, R. Scot Skinner, Troy Giambernardi, Yanli Su, Eric Hudson, James Resau, Milton Gross, George F. Vande Woude, Rick Hay, Brian Cao
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6049–6055.
https://doi.org/10.1158/1078-0432.CCR-07-0035
Published: 18 October 2007
View articletitled, Identification of a Met-Binding Peptide from a Phage Display Library
Open the PDF for Identification of a Met-Binding Peptide from a Phage Display Library in another window
Journal Articles

Nuclear Imaging of Met-Expressing Human and Canine Cancer Xenografts with Radiolabeled Monoclonal Antibodies (MetSeekTM)

Free
Rick V. Hay, Brian Cao, R. Scot Skinner, Yanli Su, Ping Zhao, Margaret F. Gustafson, Chao-Nan Qian, Bin T. Teh, Beatrice S. Knudsen, James H. Resau, Shuren Shen, David J. Waters, Milton D. Gross, George F. Vande Woude
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7064s–7069s.
https://doi.org/10.1158/1078-0432.CCR-1004-0014
Published: 03 October 2005
View articletitled, Nuclear Imaging of Met-Expressing Human and Canine Cancer Xenografts with Radiolabeled Monoclonal Antibodies (MetSeekTM)
Open the PDF for Nuclear Imaging of Met-Expressing Human and Canine Cancer Xenografts with Radiolabeled Monoclonal Antibodies (MetSeekTM) in another window
Journal Articles

Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas

Free
Yi Ren, Brian Cao, Simon Law, Yi Xie, Ping Yin Lee, Leo Cheung, Yongxong Chen, Xin Huang, Hiu Man Chan, Ping Zhao, John Luk, George Vande Woude, John Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6190–6197.
https://doi.org/10.1158/1078-0432.CCR-04-2553
Published: 06 September 2005
View articletitled, Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas
Open the PDF for Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas in another window
Journal Articles

Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma

Free
Min-Han Tan, Carl Morrison, Pengfei Wang, Ximing Yang, Carola J. Haven, Chun Zhang, Ping Zhao, Maria S. Tretiakova, Eeva Korpi-Hyovalti, John R. Burgess, Khee Chee Soo, Wei-Keat Cheah, Brian Cao, James Resau, Hans Morreau, Bin Tean Teh
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6629–6637.
https://doi.org/10.1158/1078-0432.CCR-04-0493
Published: 08 October 2004
View articletitled, Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma
Open the PDF for Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma in another window